Veterinary Infectious Disease Diagnostics Market Share

Veterinary Infectious Disease Diagnostics Market size registered a substantial CAGR in 2023 and will demonstrate a noteworthy CAGR between 2024 and 2032, propelled by government initiatives supporting animal health and diagnostics. Programs like the Animal Pandemic Preparedness Initiative (APPI) promote early disease detection. Additionally, the adoption of the One Health approach, considering animal, human, and environmental health, emphasizes the importance of accurate and timely diagnostics. These factors drive industry growth as veterinarians and healthcare professionals prioritize effective disease control measures.

For instance, in April 2023, the Ministry of Fisheries, Animal Husbandry, and Dairying initiated the Animal Pandemic Preparedness Initiative (APPI) within the framework of the One Health Approach. This program aims to tackle the risk posed by diseases that can be transmitted between animals and humans.

The veterinary infectious disease diagnostics market growth is significantly accelerated by increasing research and development activities in veterinary diagnostics. As researchers and companies focus on developing innovative and accurate diagnostic tools, new technologies, such as PCR and next-generation sequencing, are emerging. These advancements lead to improved detection methods for infectious diseases in animals, driving industry gains as veterinarians adopt these cutting-edge solutions for early and precise disease diagnosis.

For instance, in August 2022, researchers from the UC Davis School of Veterinary Medicine initiated clinical trials for enhancing treatments for feline infectious peritonitis (FIP). Patients are being enrolled at the UC Davis Veterinary Hospital for these trials.

Though the veterinary infectious disease diagnostics market is thriving, the initial investment required for advanced diagnostic technologies poses challenges to market expansion. However, this cost signifies an investment in precision and accuracy. Additionally, navigating regulatory challenges and approvals ensures that only safe and effective diagnostics enter the market, building trust among veterinarians and pet owners alike. These hurdles, though significant, ultimately contribute to the development of reliable and innovative diagnostic solutions.

Veterinary Infectious Disease Diagnostics Market Trends

Advancements in technology, such as PCR and next-generation sequencing, are propelling the industry forward. These technologies offer higher sensitivity, specificity, and the ability to detect a wide range of pathogens. Veterinary professionals can now swiftly and accurately identify infectious agents, aiding in timely treatment and disease control. This trend toward more advanced diagnostic tools is enhancing the effectiveness of veterinary care and fueling industry progression.

For instance, in March 2023, BioPerfectus introduced new PCR kits for zoonotic infectious disease diagnostics, providing an advanced solution for detecting cross-species infections.

Veterinary Infectious Disease Diagnostics Market Analysis

The viral infections segment will establish a significant foothold during 2024 and 2032, fueled by the increasing prevalence of viral diseases among animals, necessitating accurate and efficient diagnostic tools. Veterinary professionals rely on viral testing for diseases like canine parvovirus, feline leukemia virus, and avian influenza. With the demand for rapid and reliable diagnosis on the rise, the viral infections segment will emerge as a significant contributor to the market's development.

The immunodiagnostics segment will capture the largest share in the veterinary infectious disease diagnostics industry by 2032, driven by the segment's ability to offer accurate and sensitive detection of a wide range of infectious diseases in animals. Immunodiagnostic methods such as ELISA and lateral flow assays provide rapid and reliable results, making them the preferred choice among veterinarians. The increasing adoption of these techniques, in line with ongoing advancements in immunodiagnostic technologies, will position this segment as a frontrunner in the industry.

North America veterinary infectious disease diagnostics market will expand at a remarkable CAGR from 2024 to 2032, attributed to the region's advanced veterinary healthcare infrastructure, increased pet ownership rates, and rising demand for companion animal diagnostics. Additionally, the presence of key players and ongoing research and development activities contribute to North America's prominent position in the market. These factors collectively position North America as a significant contributor to the expansion of the industry.

Veterinary Infectious Disease Diagnostics Market Players

Key industry players are bolstering their market share through strategic initiatives. Their focus on research and development leads to the introduction of cutting-edge diagnostic solutions tailored to veterinarians' needs. These innovative solutions provide precise and swift testing for a wide range of infectious diseases, ultimately enhancing animal health outcomes. Moreover, partnerships with veterinary clinics and research institutions are bolstering their presence in the market, ensuring a broader reach and adoption.

Furthermore, initiatives to educate and raise awareness among veterinarians about the benefits of early disease detection are driving adoption rates. Leveraging digital platforms for marketing and distribution is also proving effective in reaching a wider customer base. Overall, by focusing on innovation, partnerships, education, and efficient distribution channels, these players are solidifying their positions and capitalizing on the growing demand for reliable veterinary infectious disease diagnostics.

Veterinary Infectious Disease Diagnostics Industry News

In June 2023, the University of Missouri College of Veterinary Medicine introduced a rabies antibody testing service at their Veterinary Medical Diagnostic Laboratory (VMDL). This service offers certified test results for companion animals traveling internationally, including to Hawaii, ensuring compliance with travel requirements.

On 15th June 2023, IDEXX Laboratories, Inc. introduced the inaugural veterinary diagnostic test for detecting kidney injury in cats and dogs.

What Information does this report contain?

How big is the global veterinary infectious disease diagnostics market?

The global market for veterinary infectious disease diagnostics surpassed USD 1.5 billion in 2022 and is expected to register a CAGR of 8-10% from 2023 to 2032.

What is the role of viral infections in the veterinary infectious disease diagnostics industry?

Viral infections segment held a significant share in the veterinary infectious disease diagnostics industry in 2022 and is anticipated to witness stellar growth owing to the rise in viral disease outbreaks.

Why is the demand for veterinary infectious disease diagnostics surging in North America?

North America veterinary infectious disease diagnostics market size is projected to record sizeable growth by 2032 due to the surging pet adoption in the U.S., and Canada.

Which companies provide veterinary infectious disease diagnostics?

Zoetis, Virbac, Idexx Laboratories, Inc., Virbac, Eurofins Technologies, and NTBIO Diagnostics Inc. are some of the leading providers of veterinary infectious disease diagnostics.

Veterinary Infectious Disease Diagnostics Market Size, Share and Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2024 – 2032